YARROW BIOSCIENCE, INC. Other Current Liabilities
YARROW BIOSCIENCE, INC. (YARW) had Other Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-06-03
- 2025-12-31: Other Liabilities, Current $0.00.
- 2025-06-30: Other Liabilities, Current $0.00.
- 2025-03-31: Other Liabilities, Current $1.31M.
- 2024-12-31: Other Liabilities, Current $1.31M.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.31M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.31M S-4/A · filed 2026-06-03 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.31M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-17 |
| 2021-09-30 | $104.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $104.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $104.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $104.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $46.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $142.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $382.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $270.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |